Crescent Grove Advisors’s Iron Mountain IRM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.08M Buy
16,389
+335
+2% +$41.1K 0.17% 101
2026
Q1
$1.71M Buy
16,054
+2,799
+21% +$278K 0.16% 102
2025
Q4
$1.11M Hold
13,255
0.1% 124
2025
Q3
$1.36M Hold
13,255
0.13% 99
2025
Q2
$1.37M Buy
13,255
+201
+2% +$18.9K 0.13% 97
2025
Q1
$1.13M Hold
13,054
0.12% 102
2024
Q4
$1.38M Buy
13,054
+211
+2% +$24.8K 0.14% 98
2024
Q3
$1.54M Buy
12,843
+571
+5% +$61.1K 0.16% 93
2024
Q2
$1.11M Hold
12,272
0.12% 106
2024
Q1
$992K Buy
12,272
+1,737
+16% +$126K 0.1% 118
2023
Q4
$737K Buy
+10,535
New +$661K 0.08% 135
2022
Q3
Sell
-5,975
Closed -$291K 266
2022
Q2
$291K Buy
+5,975
New +$314K 0.03% 209

Other funds holding IRM

Crescent Grove Advisors's IRM Position: Q2 2026 in Review

Crescent Grove Advisors increased its Iron Mountain (IRM) stake by 2.1% in Q2 2026, buying an estimated $41.1K and bringing the position to 16,389 shares worth $2.08M. The position accounts for 0.17% of the portfolio, ranked #101.

Crescent Grove Advisors first reported a position in IRM in Q2 2022 and has held it in 12 quarters since. 1,170 funds tracked by Wall St. Rank hold IRM as of Q2 2026.

  • Crescent Grove Advisors held 16,389 shares of Iron Mountain worth $2.08M as of Q2 2026.
  • Crescent Grove Advisors bought 335 Iron Mountain shares in Q2 2026, an estimated $41.1K.
  • Iron Mountain made up 0.17% of Crescent Grove Advisors's portfolio in Q2 2026, its #101 holding.
  • Crescent Grove Advisors first reported a position in Iron Mountain in Q2 2022 and has held it in 12 quarters since.
  • 1,170 funds tracked by Wall St. Rank held Iron Mountain as of Q2 2026.

Based on Crescent Grove Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.